ACHV Achieve Life Sciences | $6.49 -0.2% | 10/23/2026 | | Reiterated Rating | | Buy | 00.00% | View details for HC Wainwright rating of Achieve Life Sciences (NASDAQ:ACHV) on 10/23/2026 |
AVTX Avalo Therapeutics | $6.93 -7.0% | 10/23/2026 | | Reiterated Rating | | Buy ➝ Neutral | 00.00% | View details for HC Wainwright rating of Avalo Therapeutics (NASDAQ:AVTX) on 10/23/2026 |
ITRG Integra Resources | $2.21 -2.2% | 10/23/2026 | | Lower Price Target | $6.75 ➝ $6.50 | Buy | 00.00% | View details for HC Wainwright rating of Integra Resources (NYSEAMERICAN:ITRG) on 10/23/2026 |
BDSX Biodesix | $21.18 -11.5% | 10/22/2026 | | Reiterated Rating | | Buy | 00.00% | View details for HC Wainwright rating of Biodesix (NASDAQ:BDSX) on 10/22/2026 |
KYTX Kyverna Therapeutics | $5.39 -5.9% | 10/22/2026 | | Reiterated Rating | | Buy | 00.00% | View details for HC Wainwright rating of Kyverna Therapeutics (NASDAQ:KYTX) on 10/22/2026 |
IONS Ionis Pharmaceuticals | $42.93 -2.2% | 10/22/2026 | | Reiterated Rating | | Buy | 00.00% | View details for HC Wainwright rating of Ionis Pharmaceuticals (NASDAQ:IONS) on 10/22/2026 |
FDMT 4D Molecular Therapeutics | $10.80 -8.9% | 10/22/2026 | | Reiterated Rating | $36.00 | Buy | 00.00% | View details for HC Wainwright rating of 4D Molecular Therapeutics (NASDAQ:FDMT) on 10/22/2026 |
PBLS Parabilis Medicines | $24.44 -9.2% | 10/22/2026 | | Initiated Coverage | $40.00 | Buy | 00.00% | View details for HC Wainwright rating of Parabilis Medicines (NASDAQ:PBLS) on 10/22/2026 |
GE GE Aerospace | $285.76 -2.7% | 10/21/2026 | | Set Price Target | $375.00 | | 00.00% | View details for HC Wainwright rating of GE Aerospace (NYSE:GE) on 10/21/2026 |
MBOT Microbot Medical | $0.97 +3.4% | 10/21/2026 | | Reiterated Rating | $12.00 | Buy | 00.00% | View details for HC Wainwright rating of Microbot Medical (NASDAQ:MBOT) on 10/21/2026 |
Get the Latest News and Ratings for Your Stocks Enter your email address below to receive the latest headlines and analysts' recommendations for your stocks with our free daily email newsletter.
|
AGMB AgomAb Therapeutics | $9.05 -2.3% | 10/21/2026 | | Reiterated Rating | | Buy | 00.00% | View details for HC Wainwright rating of AgomAb Therapeutics (NASDAQ:AGMB) on 10/21/2026 |
OCS Oculis | $7.90 -2.3% | 10/21/2026 | | Reiterated Rating | $39.00 | Buy | 00.00% | View details for HC Wainwright rating of Oculis (NASDAQ:OCS) on 10/21/2026 |
LEU Centrus Energy | $102.38 -1.7% | 10/21/2026 | | Reiterated Rating | $300.00 | Buy | 00.00% | View details for HC Wainwright rating of Centrus Energy (NYSE:LEU) on 10/21/2026 |
SGP Spyglass Pharma | $28.48 +0.9% | 10/21/2026 | | Reiterated Rating | $37.00 | Buy | 00.00% | View details for HC Wainwright rating of Spyglass Pharma (NASDAQ:SGP) on 10/21/2026 |
SLN Silence Therapeutics | $19.67 +0.1% | 10/21/2026 | | Downgrade | $75.00 ➝ $20.00 | Buy ➝ Neutral | 00.00% | View details for HC Wainwright rating of Silence Therapeutics (NASDAQ:SLN) on 10/21/2026 |
OCUL Ocular Therapeutix | $6.50 -1.7% | 10/20/2026 | | Reiterated Rating | | Buy | 00.00% | View details for HC Wainwright rating of Ocular Therapeutix (NASDAQ:OCUL) on 10/20/2026 |
ABSI Absci | $9.18 -2.0% | 10/20/2026 | | Reiterated Rating | | Buy | 00.00% | View details for HC Wainwright rating of Absci (NASDAQ:ABSI) on 10/20/2026 |
PVLA Palvella Therapeutics | $125.10 -1.0% | 10/20/2026 | | Reiterated Rating | | Buy | 00.00% | View details for HC Wainwright rating of Palvella Therapeutics (NASDAQ:PVLA) on 10/20/2026 |
DRTS Alpha Tau Medical | $13.16 +2.0% | 10/20/2026 | | Reiterated Rating | $16.00 | Buy | 00.00% | View details for HC Wainwright rating of Alpha Tau Medical (NASDAQ:DRTS) on 10/20/2026 |
EYPT Eyepoint Pharmaceuticals | $0.40 -5.5% | 10/20/2026 | | Reiterated Rating | | Neutral | 00.00% | View details for HC Wainwright rating of Eyepoint Pharmaceuticals (NASDAQ:EYPT) on 10/20/2026 |
RAPP Rapport Therapeutics | $25.93 -2.3% | 10/20/2026 | | Reiterated Rating | $66.00 | Buy | 00.00% | View details for HC Wainwright rating of Rapport Therapeutics (NASDAQ:RAPP) on 10/20/2026 |
USAS Americas Gold and Silver | $3.07 -3.8% | 10/20/2026 | | Reiterated Rating | $9.25 | Buy | 00.00% | View details for HC Wainwright rating of Americas Gold and Silver (NYSEAMERICAN:USAS) on 10/20/2026 |
JANX Janux Therapeutics | $16.66 -2.3% | 10/19/2026 | | Reiterated Rating | | Buy | 00.00% | View details for HC Wainwright rating of Janux Therapeutics (NASDAQ:JANX) on 10/19/2026 |
TRDA Entrada Therapeutics | $4.41 -6.8% | 10/19/2026 | | Reiterated Rating | | Neutral | 00.00% | View details for HC Wainwright rating of Entrada Therapeutics (NASDAQ:TRDA) on 10/19/2026 |
AARD Aardvark Therapeutics | $1.39 -64.8% | 10/19/2026 | | Lower Price Target | $6.00 ➝ $4.00 | Neutral | 00.00% | View details for HC Wainwright rating of Aardvark Therapeutics (NASDAQ:AARD) on 10/19/2026 |
ADAG Adagene | $2.41 -1.2% | 10/19/2026 | | Reiterated Rating | $7.00 | Buy | 00.00% | View details for HC Wainwright rating of Adagene (NASDAQ:ADAG) on 10/19/2026 |
ANRO Alto Neuroscience | $21.96 -1.1% | 10/19/2026 | | Boost Price Target | $55.00 ➝ $60.00 | Buy | 00.00% | View details for HC Wainwright rating of Alto Neuroscience (NYSE:ANRO) on 10/19/2026 |
BWAY Brainsway | $11.25 -1.7% | 10/19/2026 | | Reiterated Rating | $19.00 | Buy | 00.00% | View details for HC Wainwright rating of Brainsway (NASDAQ:BWAY) on 10/19/2026 |
CBIO Crescent Biopharma | $12.82 -2.4% | 10/19/2026 | | Reiterated Rating | $36.00 | Buy | 00.00% | View details for HC Wainwright rating of Crescent Biopharma (NASDAQ:CBIO) on 10/19/2026 |
CLNN Clene | $3.88
| 10/19/2026 | | Reiterated Rating | | Buy | 00.00% | View details for HC Wainwright rating of Clene (NASDAQ:CLNN) on 10/19/2026 |
CYTK Cytokinetics | $61.23 -1.8% | 10/19/2026 | | Reiterated Rating | $140.00 | Buy | 00.00% | View details for HC Wainwright rating of Cytokinetics (NASDAQ:CYTK) on 10/19/2026 |
ELVN Enliven Therapeutics | $41.52 -1.0% | 10/19/2026 | | Boost Price Target | $65.00 ➝ $73.00 | Buy | 00.00% | View details for HC Wainwright rating of Enliven Therapeutics (NASDAQ:ELVN) on 10/19/2026 |
HDRN Hadron Energy | $0.75 +1.3% | 10/19/2026 | | Initiated Coverage | | Buy | 00.00% | View details for HC Wainwright rating of Hadron Energy (NASDAQ:HDRN) on 10/19/2026 |
RIGL Rigel Pharmaceuticals | $48.13 -1.5% | 10/19/2026 | | Reiterated Rating | $85.00 | Buy | 00.00% | View details for HC Wainwright rating of Rigel Pharmaceuticals (NASDAQ:RIGL) on 10/19/2026 |
SLGL Sol-Gel Technologies | $69.45 +3.1% | 10/19/2026 | | Reiterated Rating | $110.00 | Buy | 00.00% | View details for HC Wainwright rating of Sol-Gel Technologies (NASDAQ:SLGL) on 10/19/2026 |
URGN Urogen Pharma | $34.49 -1.9% | 10/19/2026 | | Reiterated Rating | $75.00 | Buy | 00.00% | View details for HC Wainwright rating of Urogen Pharma (NASDAQ:URGN) on 10/19/2026 |
UROY Uranium Royalty | $3.43 +1.5% | 10/19/2026 | | Reiterated Rating | $4.50 | Buy | 00.00% | View details for HC Wainwright rating of Uranium Royalty (NASDAQ:UROY) on 10/19/2026 |
ZNTL Zentalis Pharmaceuticals | $2.21 -8.3% | 10/19/2026 | | Reiterated Rating | $10.00 | Buy | 00.00% | View details for HC Wainwright rating of Zentalis Pharmaceuticals (NASDAQ:ZNTL) on 10/19/2026 |
UNH UnitedHealth Group | $417.97 -1.7% | 10/16/2026 | | Set Price Target | $500.00 | | 00.00% | View details for HC Wainwright rating of UnitedHealth Group (NYSE:UNH) on 10/16/2026 |
ENGN enGene | $1.56 -1.3% | 10/16/2026 | | Reiterated Rating | | Buy | 00.00% | View details for HC Wainwright rating of enGene (NASDAQ:ENGN) on 10/16/2026 |
$0. Later: $29.97. (Ad) Bill Poulos is giving away his Simple Options Trading For Beginners book through a temporary link. Once that link expires, it returns to its usual price of $29.97.
The content stays the same - plain-English lessons and a handful of proven techniques - only the price changes. Waiting means paying for something you could have gotten for free. Download your free copy before the link expires today. |
HUMA Humacyte | $0.44 +5.4% | 10/16/2026 | | Reiterated Rating | | Buy | 00.00% | View details for HC Wainwright rating of Humacyte (NASDAQ:HUMA) on 10/16/2026 |
STRO Sutro Biopharma | $9.33 -9.3% | 10/16/2026 | | Reiterated Rating | | Buy | 00.00% | View details for HC Wainwright rating of Sutro Biopharma (NASDAQ:STRO) on 10/16/2026 |
AQST Aquestive Therapeutics | $4.00 -3.1% | 10/16/2026 | | Reiterated Rating | $10.00 | Buy | 00.00% | View details for HC Wainwright rating of Aquestive Therapeutics (NASDAQ:AQST) on 10/16/2026 |
AVTX Avalo Therapeutics | $6.93 -7.0% | 10/16/2026 | | Reiterated Rating | | Buy | 00.00% | View details for HC Wainwright rating of Avalo Therapeutics (NASDAQ:AVTX) on 10/16/2026 |
OPK OPKO Health | $1.63
| 10/16/2026 | | Reiterated Rating | | Buy | 00.00% | View details for HC Wainwright rating of OPKO Health (NASDAQ:OPK) on 10/16/2026 |
NRIX Nurix Therapeutics | $25.34 -0.7% | 10/16/2026 | | Boost Price Target | $34.00 ➝ $36.00 | Buy | 00.00% | View details for HC Wainwright rating of Nurix Therapeutics (NASDAQ:NRIX) on 10/16/2026 |
EIKN Eikon Therapeutics | $7.26 -11.9% | 10/16/2026 | | Initiated Coverage | $23.00 | Buy | 00.00% | View details for HC Wainwright rating of Eikon Therapeutics (NASDAQ:EIKN) on 10/16/2026 |
EIKN Eikon Therapeutics | $7.26 -11.9% | 10/16/2026 | | Initiated Coverage | $23.00 | Buy | 00.00% | View details for HC Wainwright rating of Eikon Therapeutics (NASDAQ:EIKN) on 10/16/2026 |
SMMT Summit Therapeutics | $15.47 -0.5% | 10/15/2026 | | Reiterated Rating | | Buy | 00.00% | View details for HC Wainwright rating of Summit Therapeutics (NASDAQ:SMMT) on 10/15/2026 |
ARWR Arrowhead Pharmaceuticals | $58.02 -0.6% | 10/15/2026 | | Reiterated Rating | $120.00 | Buy | 00.00% | View details for HC Wainwright rating of Arrowhead Pharmaceuticals (NASDAQ:ARWR) on 10/15/2026 |
BEAM Beam Therapeutics | $24.05 -2.1% | 10/15/2026 | | Reiterated Rating | $80.00 | Buy | 00.00% | View details for HC Wainwright rating of Beam Therapeutics (NASDAQ:BEAM) on 10/15/2026 |
BLTE Belite Bio | $147.33 -2.0% | 10/15/2026 | | Reiterated Rating | $245.00 | Buy | 00.00% | View details for HC Wainwright rating of Belite Bio (NASDAQ:BLTE) on 10/15/2026 |
DNTH Dianthus Therapeutics | $76.78 -2.2% | 10/15/2026 | | Reiterated Rating | $158.00 | Buy | 00.00% | View details for HC Wainwright rating of Dianthus Therapeutics (NASDAQ:DNTH) on 10/15/2026 |
IBRX ImmunityBio | $8.22 -1.1% | 10/15/2026 | | Reiterated Rating | $15.00 | Buy | 00.00% | View details for HC Wainwright rating of ImmunityBio (NASDAQ:IBRX) on 10/15/2026 |
KRYS Krystal Biotech | $311.50 -2.7% | 10/15/2026 | | Reiterated Rating | $361.00 | Buy | 00.00% | View details for HC Wainwright rating of Krystal Biotech (NASDAQ:KRYS) on 10/15/2026 |
LQDA Liquidia | $42.65 +7.5% | 10/15/2026 | | Boost Price Target | $58.00 ➝ $65.00 | Buy | 00.00% | View details for HC Wainwright rating of Liquidia (NASDAQ:LQDA) on 10/15/2026 |
PRAX Praxis Precision Medicines | $252.96 -2.3% | 10/15/2026 | | Reiterated Rating | $1,201.00 | Buy | 00.00% | View details for HC Wainwright rating of Praxis Precision Medicines (NASDAQ:PRAX) on 10/15/2026 |
SGHT Sight Sciences | $8.99 -1.1% | 10/15/2026 | | Initiated Coverage | $14.00 | Buy | 00.00% | View details for HC Wainwright rating of Sight Sciences (NASDAQ:SGHT) on 10/15/2026 |
EWTX Edgewise Therapeutics | $39.31 -1.7% | 10/14/2026 | | Reiterated Rating | | Buy | 00.00% | View details for HC Wainwright rating of Edgewise Therapeutics (NASDAQ:EWTX) on 10/14/2026 |
ALEC Alector | $1.83
| 10/14/2026 | | Boost Price Target | $5.00 ➝ $8.00 | Buy | 00.00% | View details for HC Wainwright rating of Alector (NASDAQ:ALEC) on 10/14/2026 |
BMEA Biomea Fusion | $0.60 +2.6% | 10/14/2026 | | Reiterated Rating | $4.00 | Buy | 00.00% | View details for HC Wainwright rating of Biomea Fusion (NASDAQ:BMEA) on 10/14/2026 |
ETON Eton Pharmaceuticals | $50.00 0.0% | 10/14/2026 | | Reiterated Rating | $70.00 | Buy | 00.00% | View details for HC Wainwright rating of Eton Pharmaceuticals (NASDAQ:ETON) on 10/14/2026 |
EVO Evotec | $1.50 -2.6% | 10/14/2026 | | Reiterated Rating | $4.00 | Buy | 00.00% | View details for HC Wainwright rating of Evotec (NASDAQ:EVO) on 10/14/2026 |
ITRG Integra Resources | $2.21 -2.2% | 10/14/2026 | | Reiterated Rating | $6.75 | Buy | 00.00% | View details for HC Wainwright rating of Integra Resources (NYSEAMERICAN:ITRG) on 10/14/2026 |
COCH Envoy Medical | $0.60 -0.1% | 10/13/2026 | | Reiterated Rating | | Buy | 00.00% | View details for HC Wainwright rating of Envoy Medical (NASDAQ:COCH) on 10/13/2026 |
ANGO AngioDynamics | $12.36 +2.8% | 10/13/2026 | | Lower Price Target | $19.00 ➝ $18.00 | Buy | 00.00% | View details for HC Wainwright rating of AngioDynamics (NASDAQ:ANGO) on 10/13/2026 |
HRMY Harmony Biosciences | $36.13 +0.3% | 10/13/2026 | | Reiterated Rating | $55.00 | Buy | 00.00% | View details for HC Wainwright rating of Harmony Biosciences (NASDAQ:HRMY) on 10/13/2026 |
INCY Incyte | $115.71 -1.0% | 10/13/2026 | | Reiterated Rating | $152.00 | Buy | 00.00% | View details for HC Wainwright rating of Incyte (NASDAQ:INCY) on 10/13/2026 |
PALI Palisade Bio | $1.33 -1.5% | 10/13/2026 | | Reiterated Rating | $7.00 | Buy | 00.00% | View details for HC Wainwright rating of Palisade Bio (NASDAQ:PALI) on 10/13/2026 |
SNDX Syndax Pharmaceuticals | $13.40 -1.3% | 10/13/2026 | | Reiterated Rating | $38.00 | Buy | 00.00% | View details for HC Wainwright rating of Syndax Pharmaceuticals (NASDAQ:SNDX) on 10/13/2026 |
ZBIO Zenas BioPharma | $26.87 -4.8% | 10/13/2026 | | Reiterated Rating | $44.00 | Buy | 00.00% | View details for HC Wainwright rating of Zenas BioPharma (NASDAQ:ZBIO) on 10/13/2026 |
SAIL SailPoint | $21.79 +8.6% | 10/12/2026 | | Reiterated Rating | | Buy | 00.00% | View details for HC Wainwright rating of SailPoint (NASDAQ:SAIL) on 10/12/2026 |
PMN Promis Neurosciences | $8.34 -7.1% | 10/12/2026 | | Reiterated Rating | | Buy | 00.00% | View details for HC Wainwright rating of Promis Neurosciences (NASDAQ:PMN) on 10/12/2026 |
CLYM Climb Bio | $10.19 -3.3% | 10/12/2026 | | Reiterated Rating | | Buy | 00.00% | View details for HC Wainwright rating of Climb Bio (NASDAQ:CLYM) on 10/12/2026 |
LBRX LB Pharmaceuticals | $38.73 -1.8% | 10/12/2026 | | Reiterated Rating | | Buy | 00.00% | View details for HC Wainwright rating of LB Pharmaceuticals (NASDAQ:LBRX) on 10/12/2026 |
RYTM Rhythm Pharmaceuticals | $89.27 -1.8% | 10/12/2026 | | Boost Price Target | $105.00 ➝ $130.00 | Buy | 00.00% | View details for HC Wainwright rating of Rhythm Pharmaceuticals (NASDAQ:RYTM) on 10/12/2026 |
ABSI Absci | $9.18 -2.0% | 10/12/2026 | | Reiterated Rating | $16.00 | Buy | 00.00% | View details for HC Wainwright rating of Absci (NASDAQ:ABSI) on 10/12/2026 |
ABTC American Bitcoin | $7.51 -5.5% | 10/12/2026 | | Initiated Coverage | $22.00 | Buy | 00.00% | View details for HC Wainwright rating of American Bitcoin (NASDAQ:ABTC) on 10/12/2026 |
CGEN Compugen | $1.94 -1.0% | 10/12/2026 | | Reiterated Rating | $4.00 | Buy | 00.00% | View details for HC Wainwright rating of Compugen (NASDAQ:CGEN) on 10/12/2026 |
INSM Insmed | $93.39 -1.8% | 10/12/2026 | | Reiterated Rating | $220.00 | Buy | 00.00% | View details for HC Wainwright rating of Insmed (NASDAQ:INSM) on 10/12/2026 |
KOD Kodiak Sciences | $87.63 +2.2% | 10/12/2026 | | Boost Price Target | $96.00 ➝ $126.00 | Buy | 00.00% | View details for HC Wainwright rating of Kodiak Sciences (NASDAQ:KOD) on 10/12/2026 |
MIRM Mirum Pharmaceuticals | $80.39 -3.3% | 10/12/2026 | | Boost Price Target | $195.00 ➝ $200.00 | Buy | 00.00% | View details for HC Wainwright rating of Mirum Pharmaceuticals (NASDAQ:MIRM) on 10/12/2026 |
MLYS Mineralys Therapeutics | $20.55 -4.3% | 10/12/2026 | | Reiterated Rating | $56.00 | Buy | 00.00% | View details for HC Wainwright rating of Mineralys Therapeutics (NASDAQ:MLYS) on 10/12/2026 |
PVLA Palvella Therapeutics | $125.10 -1.0% | 10/12/2026 | | Lower Price Target | $270.00 ➝ $246.00 | Buy | 00.00% | View details for HC Wainwright rating of Palvella Therapeutics (NASDAQ:PVLA) on 10/12/2026 |
SOPH SOPHiA GENETICS | $7.35 +4.3% | 10/12/2026 | | Reiterated Rating | $14.00 | Buy | 00.00% | View details for HC Wainwright rating of SOPHiA GENETICS (NASDAQ:SOPH) on 10/12/2026 |
CRSP CRISPR Therapeutics | $49.39 -1.2% | 10/9/2026 | | Reiterated Rating | | Buy | 00.00% | View details for HC Wainwright rating of CRISPR Therapeutics (NASDAQ:CRSP) on 10/9/2026 |
GEVO Gevo | $1.16 +1.8% | 10/9/2026 | | Reiterated Rating | | Buy | 00.00% | View details for HC Wainwright rating of Gevo (NASDAQ:GEVO) on 10/9/2026 |
QSI Quantum-Si | $1.40 +21.7% | 10/9/2026 | | Set Price Target | $4.00 | | 00.00% | View details for HC Wainwright rating of Quantum-Si (NASDAQ:QSI) on 10/9/2026 |
COCP Cocrystal Pharma | $0.95 +4.2% | 10/9/2026 | | Reiterated Rating | | Buy | 00.00% | View details for HC Wainwright rating of Cocrystal Pharma (NASDAQ:COCP) on 10/9/2026 |
EXK Endeavour Silver | $7.46 -2.5% | 10/9/2026 | | Reiterated Rating | $17.00 | Buy | 00.00% | View details for HC Wainwright rating of Endeavour Silver (NYSE:EXK) on 10/9/2026 |
Elon Musk’s Hushed FCC Filing. Dec 8th. (Ad) Elon Musk quietly filed a document with the federal government tied to artificial intelligence, one of the largest markets in the world.
James Altucher, who previously flagged Nvidia in 2008 and Bitcoin in 2013, says the filing could rival Tesla, SpaceX and xAI combined.
Few investors know this filing exists, but that is expected to change quickly. Click here to see details on Elon Musk's newest AI filing |
AG First Majestic Silver | $14.76 -2.4% | 10/9/2026 | | Lower Price Target | $27.00 ➝ $25.50 | Buy | 00.00% | View details for HC Wainwright rating of First Majestic Silver (NYSE:AG) on 10/9/2026 |
PCRX Pacira BioSciences | $36.42 +0.2% | 10/9/2026 | | Downgrade | $38.00 ➝ $36.50 | Buy ➝ Hold | 00.00% | View details for HC Wainwright rating of Pacira BioSciences (NASDAQ:PCRX) on 10/9/2026 |
AVBP ArriVent BioPharma | $21.00 +9.4% | 10/8/2026 | | Lower Price Target | $47.00 ➝ $27.00 | Buy | 00.00% | View details for HC Wainwright rating of ArriVent BioPharma (NASDAQ:AVBP) on 10/8/2026 |
CNTB Connect Biopharma | $0.77 +0.6% | 10/8/2026 | | Reiterated Rating | | Buy | 00.00% | View details for HC Wainwright rating of Connect Biopharma (NASDAQ:CNTB) on 10/8/2026 |
CRBU Caribou Biosciences | $0.53 -4.9% | 10/8/2026 | | Downgrade | | Buy ➝ Neutral | 00.00% | View details for HC Wainwright rating of Caribou Biosciences (NASDAQ:CRBU) on 10/8/2026 |
SPTX Seaport Therapeutics | $20.61 -0.7% | 10/8/2026 | | Reiterated Rating | $50.00 | Buy | 00.00% | View details for HC Wainwright rating of Seaport Therapeutics (NASDAQ:SPTX) on 10/8/2026 |
TOYO TOYO | $3.94 +2.1% | 10/8/2026 | | Reiterated Rating | $18.00 | Buy | 00.00% | View details for HC Wainwright rating of TOYO (NASDAQ:TOYO) on 10/8/2026 |
OKYO OKYO Pharma | $1.40 -4.8% | 10/7/2026 | | Reiterated Rating | | Buy | 00.00% | View details for HC Wainwright rating of OKYO Pharma (NASDAQ:OKYO) on 10/7/2026 |
HALO Halozyme Therapeutics | $125.63 +0.9% | 10/7/2026 | | Boost Price Target | $115.00 ➝ $130.00 | Buy | 00.00% | View details for HC Wainwright rating of Halozyme Therapeutics (NASDAQ:HALO) on 10/7/2026 |
GMAB Genmab A/S | $43.79 +9.5% | 10/7/2026 | | Boost Price Target | $40.00 ➝ $50.00 | Buy | 00.00% | View details for HC Wainwright rating of Genmab A/S (NASDAQ:GMAB) on 10/7/2026 |